Texas is about to play host to the first ever delegation of innovative medical technology companies from the United Kingdom.
It is recognised that the UK has a world-leading reputation in life sciences. Its £18bn ($26.3) medical technology sector employs over 88,000 people and has changed millions of lives across the globe.
This month, the British Foreign and Commonwealth Office (FOC), its trade investment body (UKTI) and the UK’s medical technology industry body, the Association of British Healthcare Industries (ABHI), are bringing a select delegation of medical technology pioneers to Austin, San Antonio and Houston. This is the first trip of an 18-month programme.
After eight months of planning with medical centres, university hospitals and the United States Armed Forces, the British visitors will meet with Texan hospitals and life sciences organisations. The objective is to foster new relationships to develop and adopt cutting-edge medical technologies in the state.
For Texan-based companies, it’s an important opportunity to learn about and engage with the UK’s health system and understand how the market works.
Peter Ellingworth, ABHI’s Chief Executive Officer, says:
We are very excited to be strengthening relationships for the medical technology sector between the UK and this great state.
I know there is a huge amount we can learn from one another. We are honoured to be hosted by the state of Texas, as it works to become a world leader in health and life sciences.
The delegation’s members come from companies whose products and services are truly life changing:
Paxman make a scalp cooler that stops patients from losing their hair during chemotherapy. Pulse Flow Technologies make wearable technology for the treatment of diabetic foot ulcers. Snap40 make wearable tech that allows patients to stay at home and yet be monitored for vital signs and risk.